In the intricate world of pharmaceutical research and development, the selection of high-quality chemical intermediates is paramount. Among these, 1-Bromo-4-fluoronaphthalene (CAS 341-41-3) stands out as a versatile and indispensable compound. Its unique molecular structure, featuring both bromine and fluorine substituents on a naphthalene core, grants it exceptional reactivity, making it a prime choice for building complex drug molecules. As a leading manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying this critical intermediate to drive innovation in drug discovery. We understand the demand for purity and consistency that is essential for pharmaceutical applications. When you buy 1-bromo-4-fluoronaphthalene from us, you are securing a product that facilitates advanced synthetic routes, often employed in developing novel therapeutic agents, including those for oncology. Its utility in cross-coupling reactions, such as the widely used Suzuki coupling, allows chemists to efficiently create carbon-carbon bonds, a fundamental step in assembling intricate molecular frameworks. For researchers and procurement managers seeking reliable pharmaceutical intermediates, understanding the benefits of sourcing from a reputable supplier is crucial. We ensure that our 1-Bromo-4-fluoronaphthalene meets rigorous quality standards, providing the necessary foundation for successful synthesis and validation processes. Exploring the price of 1-bromo-4-fluoronaphthalene reveals that investing in a premium intermediate translates to greater efficiency and fewer synthesis failures, ultimately impacting the cost-effectiveness of drug development. NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing, especially for bulk purchases, making it an attractive option for pharmaceutical companies worldwide. Choosing the right chemical building blocks can significantly accelerate the path from laboratory discovery to market-ready treatments. Our commitment is to provide the materials that empower your research and manufacturing needs, cementing our role as a key partner in advancing healthcare.